Allspring Global Investments
ALDX icon

Allspring Global Investments’s Aldeyra Therapeutics ALDX Stock Holding History

Allspring Global Investments’s Portfolio ALDX Stock Details ALDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-12,189
Closed -$42.8K – 2299
2023
Q4 		$42.8K Sell
12,189
-6,429
-35% -$19.8K ﹤0.01% 1900
2023
Q3 		$124K Buy
+18,618
New +$138K ﹤0.01% 1922

Other funds holding ALDX

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Allspring Global Investments's ALDX Position: Q1 2024 in Review

Allspring Global Investments sold out of Aldeyra Therapeutics (ALDX) in Q1 2024, closing a stake of 12,189 shares — an estimated $42.8K sold.

Allspring Global Investments first reported a position in ALDX in Q3 2023 and held it in 2 quarters. The position peaked at $124K in Q3 2023. 102 funds tracked by Wall St. Rank hold ALDX as of Q1 2024.

  • Allspring Global Investments reported no remaining Aldeyra Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Allspring Global Investments sold 12,189 Aldeyra Therapeutics shares in Q1 2024, an estimated $42.8K.
  • Allspring Global Investments first reported a position in Aldeyra Therapeutics in Q3 2023 and held it in 2 quarters.
  • Allspring Global Investments's Aldeyra Therapeutics position peaked at $124K in Q3 2023.
  • 102 funds tracked by Wall St. Rank held Aldeyra Therapeutics as of Q1 2024.

Based on Allspring Global Investments's 13F filing for Q1 2024, filed 18 Apr 2024.